Serial 87668733
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87668733
- Registration number
- 6208266
- Mark type
- Design / logo
- Filed
- 01 Nov 2017
- Published for opposition
- 15 Sept 2020
- Registered
- 01 Dec 2020
- Attorney of record
- Sam Yip
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
- Class 010 — Medical apparatus: Medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, non-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing neurodegenerative diseases for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
- Class 042 — Scientific and technological services: Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of neurodegenerative diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders
Owner
- Aptorum Group Limited, Hong Kong, KY
- Aptorum Group Limited, Hong Kong, KY
- Aptorum Group Limited, Central, KY
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 06 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Oct 2020 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 06 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Aug 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 30 Jul 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jul 2020 — CASE RETURNED TO EXAMINATION
- 23 Jul 2020 — NOTICE OF ALLOWANCE CANCELLED